S-1/A: Abacus Life Eyes $15 Million in Senior Notes Offering to Refinance Debt and Bolster Corporate Funds

Sentiment:

Debt Offering Prospectus


Abacus Life, Inc. announces an offering of $15 million in 9.875% Fixed Rate Senior Notes due 2028 to refinance debt and for general corporate purposes.

Capital raiseAbacus Life, Inc. is offering $15,000,000 aggregate principal amount of its 9.875% Fixed Rate Senior Notes due 2028.The underwriters have an option to purchase up to an additional $2,250,000 aggregate principal amount of the notes.

Summary

  • Abacus Life, Inc. is offering an additional $15 million in 9.875% Fixed Rate Senior Notes due 2028.
  • The notes will be fully fungible with the existing notes and treated as a single series.
  • The aggregate principal amount outstanding after the offering will be $50.65 million, or $52.9 million if the underwriters' option is exercised fully.
  • The company may redeem the notes on or after February 15, 2027, at 100% of the principal amount plus accrued interest.
  • Holders can require the company to repurchase the notes at 100% of the principal amount plus accrued interest upon a Change of Control Repurchase Event.
  • The notes are senior unsecured obligations, ranking equally with other senior unsecured debt and subordinated to secured debt and subsidiary obligations.
  • The offering is expected to close around February 15, 2024.
  • The company intends to use the net proceeds of approximately $14.25 million to refinance other outstanding indebtedness and for general corporate purposes.

Sentiment

Score: 6

Explanation: The document presents a neutral outlook. While it highlights the company's plans for debt refinancing and corporate purposes, it also acknowledges the risks associated with the notes and the company's business.

Positives

  • The offering provides Abacus Life with capital to refinance existing debt and for general corporate purposes.
  • The notes are fully fungible with existing notes, which may improve liquidity.
  • The company has the option to redeem the notes, providing flexibility in managing its capital structure.
  • The notes are listed on NASDAQ, which may provide liquidity for investors.

Negatives

  • The notes are unsecured and effectively subordinated to any existing and future secured indebtedness.
  • The notes are structurally subordinated to the indebtedness and other liabilities of the company's subsidiaries.
  • The indenture contains limited protection for noteholders.
  • There may not be an active and liquid trading market for the notes.
  • The company may choose to redeem the notes when prevailing interest rates are relatively low.
  • The company may not be able to repurchase the notes upon a Change of Control Repurchase Event.

Risks

  • The notes are unsecured and effectively subordinated to secured debt.
  • The notes are structurally subordinated to subsidiary debt.
  • The indenture provides limited protection for noteholders.
  • An active trading market for the notes may not develop.
  • The company may redeem the notes when interest rates are low.
  • An increase in interest rates could decrease the fair value of the notes.
  • A credit rating downgrade could decrease the market value of the notes.
  • Default on other indebtedness could prevent payment on the notes.
  • The company may not be able to repurchase the notes upon a Change of Control Repurchase Event.
  • The company's valuation of life insurance policies is uncertain.
  • The company could fail to accurately forecast life expectancies.
  • The company may experience increased competition.
  • There is a risk of fraud in the origination of life insurance policies.
  • The company may become subject to claims by life insurance companies, individuals and their families, or regulatory authorities.
  • The company faces privacy and cyber security risks.
  • The company is subject to U.S. privacy laws and regulations.
  • The company's business may be subject to additional or different government regulation in the future.
  • There is currently no direct legal authority regarding the proper federal tax treatment of life settlements.
  • The failure of the company to accurately and timely track and pay premium payments on the life insurance policies it holds could result in the lapse of such policies.
  • The originating life insurance company may increase the cost of insurance premiums.
  • The company may not be able to liquidate its life insurance policies.
  • The company assumes the credit risk associated with life insurance companies.
  • The company's success is dependent upon the services of its management and employees.
  • The company's intellectual property rights may not adequately protect the company's business.
  • The company may become subject to costly intellectual property disputes.
  • The ongoing COVID-19 pandemic, along with rising interest rates and inflation, may disrupt the ability of the company and its providers to originate life settlement policies.
  • We have identified material weaknesses in our internal control over financial reporting.
  • If we do not develop and implement all required accounting practices and policies, we may be unable to provide the financial information required of a public company in a timely and reliable manner.
  • Our ability to raise capital in the future may be limited, or may be unavailable on acceptable terms, if at all.
  • Our management has limited experience in operating a public company.

Future Outlook

The company intends to use the net proceeds from the offering to refinance other outstanding indebtedness and for general corporate purposes.

Industry Context

This offering is part of Abacus Life's strategy to manage its capital structure and fund its operations in the life settlements market, a sector that has seen increasing interest from investors seeking alternative asset classes.

Comparison to Industry Standards

  • Comparable companies in the alternative asset management space include firms like Apollo Global Management and Blackstone, which also utilize debt financing as part of their capital structure.
  • However, Abacus Life's focus on life settlements provides a unique risk profile compared to broader alternative asset portfolios.
  • The 9.875% interest rate is relatively high, reflecting the company's credit risk and the current interest rate environment.
  • Other companies with similar credit ratings may have different interest rates based on their specific business models and financial performance.

Stakeholder Impact

  • Shareholders may experience a dilution of their ownership if the underwriters exercise their overallotment option.
  • Employees may benefit from the company's improved financial stability and growth prospects.
  • Customers may see enhanced services and product offerings as a result of the company's investment in its business.
  • Creditors will be affected by the company's refinancing of existing debt.

Next Steps

  • The offering is expected to close on or about February 15, 2024.
  • The company will use the net proceeds to refinance other outstanding indebtedness and for general corporate purposes.
  • The company intends to apply to list the notes on NASDAQ under the trading symbol ABLLL.

Key Dates

DateDescription
2024-02-15Initial interest payment date
2027-02-15Earliest date for optional redemption of the notes
2028-11-15Maturity date of the notes

Keywords

senior notes, fixed rate, debt, refinancing, Abacus Life, offering, securities, indenture, redemption, interest, unsecured, obligations, principal, subsidiaries, repurchase, control, change

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.